Literature DB >> 23052597

Low vitamin B12 levels and gastric parietal cell antibodies in patients with aquaporin-4 antibody-positive neuromyelitis optica spectrum disorders.

S Jarius, F Paul, K Ruprecht, B Wildemann.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23052597     DOI: 10.1007/s00415-012-6677-1

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


× No keyword cloud information.
  15 in total

1.  NMO-IgG in the diagnosis of neuromyelitis optica.

Authors:  S Jarius; D Franciotta; R Bergamaschi; H Wright; E Littleton; J Palace; R Hohlfeld; A Vincent
Journal:  Neurology       Date:  2007-02-07       Impact factor: 9.910

2.  Autoantibodies against aquaporin-4 in patients with neuropsychiatric systemic lupus erythematosus and primary Sjögren's syndrome.

Authors:  Klaus-Peter Wandinger; Martin Stangel; Torsten Witte; Patrick Venables; Peter Charles; Sven Jarius; Brigitte Wildemann; Christian Probst; Christof Iking-Konert; Matthias Schneider
Journal:  Arthritis Rheum       Date:  2010-04

Review 3.  Neuromyelitis optica spectrum disorders in patients with myasthenia gravis: ten new aquaporin-4 antibody positive cases and a review of the literature.

Authors:  S Jarius; F Paul; D Franciotta; J de Seze; C Münch; M Salvetti; K Ruprecht; M Liebetrau; K P Wandinger; G Akman-Demir; A Melms; W Kristoferitsch; B Wildemann
Journal:  Mult Scler       Date:  2011-12-19       Impact factor: 6.312

4.  Myasthenia gravis and neuromyelitis optica spectrum disorder: a multicenter study of 16 patients.

Authors:  M I Leite; E Coutinho; M Lana-Peixoto; S Apostolos; P Waters; D Sato; L Melamud; M Marta; A Graham; J Spillane; A M Villa; D Callegaro; E Santos; A Martins da Silva; S Jarius; R Howard; I Nakashima; G Giovannoni; C Buckley; D Hilton-Jones; A Vincent; J Palace
Journal:  Neurology       Date:  2012-05-02       Impact factor: 9.910

5.  Frequency and syndrome specificity of antibodies to aquaporin-4 in neurological patients with rheumatic disorders.

Authors:  Sven Jarius; Christian Jacobi; Jerome de Seze; Helene Zephir; Friedemann Paul; Diego Franciotta; Paulus Rommer; Simone Mader; Ingo Kleiter; Markus Reindl; Gulsen Akman-Demir; Thomas Seifert-Held; Wolfgang Kristoferitsch; Arthur Melms; Klaus-Peter Wandinger; Brigitte Wildemann
Journal:  Mult Scler       Date:  2011-05-04       Impact factor: 6.312

Review 6.  AQP4 antibodies in neuromyelitis optica: diagnostic and pathogenetic relevance.

Authors:  Sven Jarius; Brigitte Wildemann
Journal:  Nat Rev Neurol       Date:  2010-07       Impact factor: 42.937

Review 7.  Mechanisms of disease: aquaporin-4 antibodies in neuromyelitis optica.

Authors:  Sven Jarius; Friedemann Paul; Diego Franciotta; Patrick Waters; Frauke Zipp; Reinhard Hohlfeld; Angela Vincent; Brigitte Wildemann
Journal:  Nat Clin Pract Neurol       Date:  2008-03-11

Review 8.  Biochemical pathogenesis of subacute combined degeneration of the spinal cord and brain.

Authors:  R Surtees
Journal:  J Inherit Metab Dis       Date:  1993       Impact factor: 4.982

9.  High prevalence of cobalamin deficiency in elderly outpatients.

Authors:  L C Pennypacker; R H Allen; J P Kelly; L M Matthews; J Grigsby; K Kaye; J Lindenbaum; S P Stabler
Journal:  J Am Geriatr Soc       Date:  1992-12       Impact factor: 5.562

10.  IgG marker of optic-spinal multiple sclerosis binds to the aquaporin-4 water channel.

Authors:  Vanda A Lennon; Thomas J Kryzer; Sean J Pittock; A S Verkman; Shannon R Hinson
Journal:  J Exp Med       Date:  2005-08-08       Impact factor: 14.307

View more
  12 in total

1.  A case of simultaneous neuromyelitis optica spectrum disorder and subacute combined degeneration.

Authors:  Nobuyuki Ishii; Hitoshi Mochizuki; Toshiyuki Takahashi; Kazutaka Shiomi; Masamitsu Nakazato
Journal:  Neurol Sci       Date:  2013-03-02       Impact factor: 3.307

2.  [Therapeutic options for autoimmune encephalomyelitis].

Authors:  N Borisow; H Prüss; F Paul
Journal:  Nervenarzt       Date:  2013-04       Impact factor: 1.214

3.  The history of neuromyelitis optica.

Authors:  Sven Jarius; Brigitte Wildemann
Journal:  J Neuroinflammation       Date:  2013-01-15       Impact factor: 8.322

Review 4.  The investigation of acute optic neuritis: a review and proposed protocol.

Authors:  Axel Petzold; Mike P Wattjes; Fiona Costello; Jose Flores-Rivera; Clare L Fraser; Kazuo Fujihara; Jacqueline Leavitt; Romain Marignier; Friedemann Paul; Sven Schippling; Christian Sindic; Pablo Villoslada; Brian Weinshenker; Gordon T Plant
Journal:  Nat Rev Neurol       Date:  2014-07-08       Impact factor: 42.937

Review 5.  Neuromyelitis optica: clinical features, immunopathogenesis and treatment.

Authors:  S Jarius; B Wildemann; F Paul
Journal:  Clin Exp Immunol       Date:  2014-05       Impact factor: 4.330

Review 6.  Aquaporin-4 autoimmunity.

Authors:  Anastasia Zekeridou; Vanda A Lennon
Journal:  Neurol Neuroimmunol Neuroinflamm       Date:  2015-05-21

Review 7.  Neuromyelitis optica spectrum disorders: An update.

Authors:  Lekha Pandit
Journal:  Ann Indian Acad Neurol       Date:  2015-09       Impact factor: 1.383

Review 8.  Update on the diagnosis and treatment of neuromyelitis optica: recommendations of the Neuromyelitis Optica Study Group (NEMOS).

Authors:  Corinna Trebst; Sven Jarius; Achim Berthele; Friedemann Paul; Sven Schippling; Brigitte Wildemann; Nadja Borisow; Ingo Kleiter; Orhan Aktas; Tania Kümpfel
Journal:  J Neurol       Date:  2013-11-23       Impact factor: 4.849

9.  Systemic Lupus Erythematosus (SLE) Complicated by Neuromyelitis Optica (NMO - Devic's Disease): Clinic-Pathological Report and Review of the Literature.

Authors:  Mohammad Adawi; Bishara Bisharat; Abdalla Bowirrat
Journal:  Clin Med Insights Case Rep       Date:  2014-06-02

Review 10.  Complexity and wide range of neuromyelitis optica spectrum disorders: more than typical manifestations.

Authors:  Jinming Han; Meng-Ge Yang; Jie Zhu; Tao Jin
Journal:  Neuropsychiatr Dis Treat       Date:  2017-10-20       Impact factor: 2.570

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.